NCT00338338View on ClinicalTrials.gov

The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

November 7, 2005

Primary Completion Date

September 14, 2007

Study Completion Date

September 14, 2007

Conditions

Uncomplicated HypertensionHypertensionEssential

Interventions

DRUG

Lacidipine 4 or 6 mg (oral)

DRUG

Amlodipine 5 or 10 mg(oral)

Trial Locations (1)

100

GSK Investigational Site, Taipei

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00338338 - The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients | Biotech Hunter | Biotech Hunter